Related Experiment Video

Updated: May 13, 2026

Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays
07:42

Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays

Published on: September 19, 2018

Establishing the role of tyrosine kinase 2 in cancer

Caroline Ubel1, Stephanie Mousset, Denis Trufa

  • 1Laboratory of Cellular and Molecular Lung Immunology; Institute of Molecular Pneumology; University of Erlangen-Nürnberg, Erlangen, Germany.

Oncoimmunology
|March 14, 2013
PubMed

Insights

Tyrosine kinase 2 (TYK2) deficiency impairs anti-tumor immunity, increasing cancer susceptibility. However, inhibiting TYK2 may offer therapeutic benefits in cancer treatment due to its role in growth factor signaling.

Area of Science:

  • Immunology
  • Oncology
  • Molecular Biology

Background:

  • Tyrosine kinase 2 (TYK2) is crucial for cytokine signaling.
  • TYK2 deficiency is linked to infections, hyper IgE syndrome, and asthma.
  • The role of TYK2 in cancer development and progression remains unclear.

Purpose of the Study:

  • To investigate the precise role of TYK2 in oncogenesis and tumor progression.
  • To explore the dual role of TYK2 in anti-tumor immunity and cancer signaling pathways.

Main Methods:

  • Analysis of tumor development in Tyk2-deficient mice.
  • Assessment of cytotoxic CD8+ T-cell responses.
  • Evaluation of Type I interferon signaling pathways.
  • Investigation of TYK2's downstream signaling from growth factor receptors.

Main Results:

  • Tyk2-deficient mice exhibit impaired cytotoxic CD8+ T-cell antitumor responses.
  • This impairment is attributed to deficient Type I interferon signaling.
  • Mice lacking TYK2 show increased susceptibility to tumor development.
  • TYK2 acts downstream of hyperactivated growth factor receptors common in cancer.

Conclusions:

  • TYK2 plays a critical role in maintaining anti-tumor immune surveillance.
  • Deficiency in TYK2 compromises the immune system's ability to fight tumors.
  • Targeting TYK2 may represent a novel therapeutic strategy for cancer treatment.
Keywords:
JAK-STAT signallingTYK2cancercytokineslung cancertumor therapy

More Related Videos

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia10:49

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

Published on: September 18, 2013

Assessing Cellular Target Engagement by SHP2 (PTPN11) Phosphatase Inhibitors08:45

Assessing Cellular Target Engagement by SHP2 (PTPN11) Phosphatase Inhibitors

Published on: July 17, 2020

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...